NSCI Stock Overview
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Nanalysis Scientific Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.45 |
| 52 Week High | CA$0.66 |
| 52 Week Low | CA$0.34 |
| Beta | 0.77 |
| 1 Month Change | 18.42% |
| 3 Month Change | 12.50% |
| 1 Year Change | -26.23% |
| 3 Year Change | -8.16% |
| 5 Year Change | n/a |
| Change since IPO | -18.18% |
Recent News & Updates
Recent updates
Benign Growth For Nanalysis Scientific Corp. (CVE:NSCI) Underpins Stock's 25% Plummet
Mar 24
Nanalysis Scientific Corp. (CVE:NSCI) Shares Fly 43% But Investors Aren't Buying For Growth
Feb 08We Think Nanalysis Scientific (CVE:NSCI) Has A Fair Chunk Of Debt
Jan 31Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?
Aug 26Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking
Apr 17Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?
Dec 08Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?
Jul 15Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?
Jan 24Is Nanalysis Scientific (CVE:NSCI) Using Debt Sensibly?
Mar 29Nanalysis Scientific (CVE:NSCI) Has Debt But No Earnings; Should You Worry?
Dec 14
Shareholder Returns
| NSCI | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 21.6% | 0.6% | 0.7% |
| 1Y | -26.2% | -25.7% | 5.5% |
Return vs Industry: NSCI matched the Canadian Medical Equipment industry which returned -25.7% over the past year.
Return vs Market: NSCI underperformed the Canadian Market which returned 5.5% over the past year.
Price Volatility
| NSCI volatility | |
|---|---|
| NSCI Average Weekly Movement | 13.0% |
| Medical Equipment Industry Average Movement | 11.4% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: NSCI's share price has been volatile over the past 3 months.
Volatility Over Time: NSCI's weekly volatility (13%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 249 | Sean Krakiwsky | www.nanalysis.com |
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K’Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Nanalysis Scientific Corp. Fundamentals Summary
| NSCI fundamental statistics | |
|---|---|
| Market cap | CA$50.86m |
| Earnings (TTM) | -CA$16.96m |
| Revenue (TTM) | CA$25.87m |
2.0x
P/S Ratio-3.0x
P/E RatioIs NSCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NSCI income statement (TTM) | |
|---|---|
| Revenue | CA$25.87m |
| Cost of Revenue | CA$21.74m |
| Gross Profit | CA$4.13m |
| Other Expenses | CA$21.10m |
| Earnings | -CA$16.96m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 29, 2024
| Earnings per share (EPS) | -0.15 |
| Gross Margin | 15.98% |
| Net Profit Margin | -65.57% |
| Debt/Equity Ratio | 61.2% |
How did NSCI perform over the long term?
See historical performance and comparison